Edition:
United States

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

5,880JPY
22 Jan 2018
Change (% chg)

¥0 (+0.00%)
Prev Close
¥5,880
Open
¥5,850
Day's High
¥5,880
Day's Low
¥5,800
Volume
586,100
Avg. Vol
848,877
52-wk High
¥6,020
52-wk Low
¥3,280

Latest Key Developments (Source: Significant Developments)

CHUGAI PHARMACEUTICAL says filing of patent infringement lawsuit and petition for provisional disposition order
Tuesday, 9 Jan 2018 01:29am EST 

Jan 9 (Reuters) - CHUGAI PHARMACEUTICAL Co Ltd <4519.T> ::Says it filed an application for assisting intervention with Zenyaku Kogyo Co Ltd in a lawsuit that Genentech Inc filed, wherein the plaintiff demands prohibition of sales etc. of Rituxan® Injection, against Sandoz K.K and Kyowa Hakko Kirin Co Ltd.Says the company has also filed an application for assisting intervention in a petition for provisional disposition order that has been filed with the lawsuit.  Full Article

Chiome Bioscience says termination of joint research contract
Monday, 18 Dec 2017 03:36am EST 

Dec 18 (Reuters) - Chiome Bioscience Inc <4583.T>:Says it announces termination of candidate antibody related joint research contract, which was signed between the co and CHUGAI PHARMACEUTICAL CO LTD <<<4519.T>>>, as the contract has expired on Dec. 31 .  Full Article

Chugai Pharmaceutical says change of chief executive officer
Tuesday, 12 Dec 2017 03:16am EST 

Dec 12 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says it names current president and chief operating officer Tatsuro Kosaka as chief executive officer and president, effective late March 2018.  Full Article

R&I affirms Chugai Pharmaceutical's rating at "AA-" and says stable outlook -R&I
Thursday, 16 Nov 2017 01:32am EST 

Nov 16 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA-" -R&I.Says rating outlook stable -R&I.  Full Article

Marketing and manufacturing right transfer of 13 long-term listed products from Chugai Pharmaceutical to Taiyo Pharma
Tuesday, 14 Nov 2017 05:17am EST 

Nov 14 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says it and TAIYO HOLDINGS CO LTD <<<4626.T>>> announced today that they have entered into an agreement, under which the co and F. Hoffmann-La Roche, Ltd. will transfer the marketing authorizations, including marketing and manufacturing rights, of 13 long-term listed products manufactured and marketed in Japan by Chugai to TAIYO Pharma Co., Ltd., a wholly owned subsidiary of Taiyo Holdings.  Full Article

Chugai Pharmaceutical says lawsuit on patent infringement concerning Herceptin® injection and petition for provisional disposition order
Friday, 8 Sep 2017 02:26am EDT 

Sept 8 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says co has filed a lawsuit and a petition for provisional disposition order against Nippon Kayaku Co.,Ltd <<<4272.T>>>, demanding the suspension of manufacturing and distribution of the biosimilar of anti-HER2 monoclonal antibody Herceptin® injection 60 and 150 (Herceptin® injection) .Genentech Inc, a U.S.-based firm, is a patent holder and co is the exclusive licensee of Herceptin® injection .Says co and Genentech are the co-plaintiff of the lawsuit.  Full Article

Chugai Pharmaceutical aims to increase core oper profit to more than 100 bln Yen in year ending Dec. 2019 - Nikkei
Monday, 21 Aug 2017 01:28pm EDT 

Aug 21 (Reuters) - Nikkei::Chugai Pharmaceutical Co Ltd aims to increase its core operating profit to more than 100 billion yen ($920 million) in the year ending December 2019 - Nikkei.  Full Article

Chugai Pharmaceutical sells trusted beneficial rights of property
Friday, 12 May 2017 03:01am EDT 

May 12 (Reuters) - Chugai Pharmaceutical Co Ltd <1491.T>: :* Says it has sold the trusted beneficial rights of Tokyo-based property on May 12.  Full Article

Baxalta files lawsuit against Chugai Pharmaceutical and Genentech
Wednesday, 10 May 2017 11:03pm EDT 

May 11(Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says Baxalta filed a lawsuit against the company and Genentech Inc., in U.S. on May 4.Says the lawsuit is mainly for a judgment for an injunction against infringement of patent right.  Full Article

Chugai Pharmaceutical to issue 123,000 shares for 469.9 mln yen
Thursday, 23 Mar 2017 04:05am EDT 

Chugai Pharmaceutical Co Ltd <4519.T>:Says it plans to issue 123,000 shares for 469.9 million yen in total.  Full Article

BRIEF-Chugai Pharmaceutical To Invest 25 Bln Yen Into A Singapore Research Center By 2021-Nikkei‍​

* CHUGAI PHARMACEUTICAL LOOKS TO INVEST SOME 25 BILLION YEN INTO A SINGAPORE RESEARCH CENTER FOR BIOPHARMACEUTICALS BY 2021 - NIKKEI‍​ Source text :(s.nikkei.com/2CitZyn) Further company coverage: (bangalore.newsroom@thomsonreuters.com)